María Pilar Solís-Hernández

Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A

Javier Martín‐Broto, Jerónimo Martínez-García, David S. Moura et al. · Signal Transduction and Targeted Therapy · 2023 · 41 citations · Full text

Medicine, Oncology, Pharmacology +11

Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)

María Pilar Solís-Hernández, A. Fernández del Valle, Alberto Carmona‐Bayonas et al. · British Journal of Cancer · 2019 · 37 citations · Full text

Medicine, Oncology, Radiology +17

Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character

Ainara Crespo, Olivia García‐Suárez, Ivan Fernández‐Vega et al. · BMC Cancer · 2018 · 22 citations · Full text

Medicine, Molecular Biology, Oncology +17

Alterations in the Expression of the Genes Responsible for the Synthesis of Heparan Sulfate in Brains With Alzheimer Disease

Natalia Pérez-López, Carla Martín, Beatriz García et al. · Journal of Neuropathology & Experimental Neurology · 2021 · 12 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Proof of concept for the use of trained sniffer dogs to detect osteosarcoma

Agustín Ortal, Aida Rodríguez, María Pilar Solís-Hernández et al. · Scientific Reports · 2022 · 10 citations · Full text

Medicine, Cancer Biology, Oncology +14